677 related articles for article (PubMed ID: 33258908)
1. Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis.
Kumar NP; Moideen K; Nancy A; Viswanathan V; Thiruvengadam K; Sivakumar S; Hissar S; Nair D; Banurekha VV; Kornfeld H; Babu S
JAMA Netw Open; 2020 Dec; 3(12):e2027754. PubMed ID: 33258908
[TBL] [Abstract][Full Text] [Related]
2. Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Are Potential Biomarkers of Pulmonary and Extra-Pulmonary Tuberculosis.
Kathamuthu GR; Kumar NP; Moideen K; Nair D; Banurekha VV; Sridhar R; Baskaran D; Babu S
Front Immunol; 2020; 11():419. PubMed ID: 32218787
[TBL] [Abstract][Full Text] [Related]
3. Predictive Value of Matrix Metalloproteinases and Their Inhibitors for Mortality in Septic Patients: A Cohort Study.
Serrano-Gomez S; Burgos-Angulo G; Niño-Vargas DC; Niño ME; Cárdenas ME; Chacón-Valenzuela E; McCosham DM; Peinado-Acevedo JS; Lopez MM; Cunha F; Pazin-Filho A; Ilarraza R; Schulz R; Torres-Dueñas D
J Intensive Care Med; 2020 Jan; 35(1):95-103. PubMed ID: 28931365
[TBL] [Abstract][Full Text] [Related]
4. The role of matrix metalloproteinases in patients with pulmonary hypertension: data from a prospective study.
Marc A; Pop C; Sitar-Taut AV; Budisan L; Berindan-Neagoe I; Pop D
BMC Cardiovasc Disord; 2021 Dec; 21(1):607. PubMed ID: 34930125
[TBL] [Abstract][Full Text] [Related]
5. Imbalances between matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in maternal serum during preterm labor.
Tency I; Verstraelen H; Kroes I; Holtappels G; Verhasselt B; Vaneechoutte M; Verhelst R; Temmerman M
PLoS One; 2012; 7(11):e49042. PubMed ID: 23145060
[TBL] [Abstract][Full Text] [Related]
6. Plasma biomarkers for distinguishing etiologic subtypes of thoracic aortic aneurysm disease.
Ikonomidis JS; Ivey CR; Wheeler JB; Akerman AW; Rice A; Patel RK; Stroud RE; Shah AA; Hughes CG; Ferrari G; Mukherjee R; Jones JA
J Thorac Cardiovasc Surg; 2013 May; 145(5):1326-33. PubMed ID: 23312977
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
[TBL] [Abstract][Full Text] [Related]
8. Combined evaluation of matrix metalloproteinases and their inhibitors has better clinical utility in oral cancer.
Singh RD; Nilayangode H; Patel JB; Shah FD; Shukla SN; Shah PM; Patel PS
Int J Biol Markers; 2011; 26(1):27-36. PubMed ID: 21337314
[TBL] [Abstract][Full Text] [Related]
9. The association of vascular endothelial growth factor, metalloproteinases and their tissue inhibitors with cardiovascular risk factors in the metabolic syndrome.
Erman H; Gelisgen R; Cengiz M; Tabak O; Erdenen F; Uzun H
Eur Rev Med Pharmacol Sci; 2016; 20(6):1015-22. PubMed ID: 27049251
[TBL] [Abstract][Full Text] [Related]
10. Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome.
Gomes VA; Vieira CS; Jacob-Ferreira AL; Belo VA; Soares GM; Fernandes JB; Ferriani RA; Tanus-Santos JE
Mol Cell Biochem; 2011 Jul; 353(1-2):251-7. PubMed ID: 21437624
[TBL] [Abstract][Full Text] [Related]
11. Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort.
Todd JL; Vinisko R; Liu Y; Neely ML; Overton R; Flaherty KR; Noth I; Newby LK; Lasky JA; Olman MA; Hesslinger C; Leonard TB; Palmer SM; Belperio JA;
BMC Pulm Med; 2020 Mar; 20(1):64. PubMed ID: 32171287
[TBL] [Abstract][Full Text] [Related]
12. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
Chen CH; Lin KC; Yu DT; Yang C; Huang F; Chen HA; Liang TH; Liao HT; Tsai CY; Wei JC; Chou CT
Rheumatology (Oxford); 2006 Apr; 45(4):414-20. PubMed ID: 16287916
[TBL] [Abstract][Full Text] [Related]
13. MMPs/TIMPs imbalances in the peripheral blood and cerebrospinal fluid are associated with the pathogenesis of HIV-1-associated neurocognitive disorders.
Xing Y; Shepherd N; Lan J; Li W; Rane S; Gupta SK; Zhang S; Dong J; Yu Q
Brain Behav Immun; 2017 Oct; 65():161-172. PubMed ID: 28487203
[TBL] [Abstract][Full Text] [Related]
14. Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia.
Lorenzl S; Buerger K; Hampel H; Beal MF
Int Psychogeriatr; 2008 Feb; 20(1):67-76. PubMed ID: 17697439
[TBL] [Abstract][Full Text] [Related]
15. Dynamic changes of matrix metalloproteinases and their tissue inhibitors in severe sepsis.
Mühl D; Nagy B; Woth G; Falusi B; Bogár L; Weber G; Lantos J
J Crit Care; 2011 Dec; 26(6):550-5. PubMed ID: 21530151
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with moderate and severe traumatic brain injury.
Zheng K; Li C; Shan X; Liu H; Fan W; Wang Z; Zheng P
Neurol India; 2013; 61(6):606-9. PubMed ID: 24441327
[TBL] [Abstract][Full Text] [Related]
17. Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis.
Noji Y; Kajinami K; Kawashiri MA; Todo Y; Horita T; Nohara A; Higashikata T; Inazu A; Koizumi J; Takegoshi T; Mabuchi H
Clin Chem Lab Med; 2001 May; 39(5):380-4. PubMed ID: 11434385
[TBL] [Abstract][Full Text] [Related]
18. Plasma profiles of matrix metalloproteinases and tissue inhibitors of the metalloproteinases predict recurrence of atrial fibrillation following cardioversion.
Mukherjee R; Akar JG; Wharton JM; Adams DK; McClure CD; Stroud RE; Rice AD; DeSantis SM; Spinale FG; Gold MR
J Cardiovasc Transl Res; 2013 Aug; 6(4):528-35. PubMed ID: 23722357
[TBL] [Abstract][Full Text] [Related]
19. Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure.
Wilson EM; Gunasinghe HR; Coker ML; Sprunger P; Lee-Jackson D; Bozkurt B; Deswal A; Mann DL; Spinale FG
J Card Fail; 2002 Dec; 8(6):390-8. PubMed ID: 12528092
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases, tissue inhibitors of metalloproteinases, aminoterminal propeptide of procollagen type III, and hyaluronan in sera and tissue of patients with capsular contracture after augmentation with Trilucent breast implants.
Ulrich D; Lichtenegger F; Eblenkamp M; Repper D; Pallua N
Plast Reconstr Surg; 2004 Jul; 114(1):229-36. PubMed ID: 15220598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
